NOW Form 144 Shows 1,762-Share Sale After Restricted Vesting
Rhea-AI Filing Summary
Form 144 notice shows a proposed sale of 1,762 shares of Common stock through Fidelity Brokerage Services (900 Salem St, Smithfield, RI) with an aggregate market value of $1,526,684.90 and approximately 208,000,000 shares outstanding. The securities were acquired on 08/17/2025 via restricted stock vesting from the issuer and the payment is listed as compensation. The approximate date of sale is 08/18/2025. The filing also reports three prior sales by Gina Marie Mastantuono: 118 shares on 05/19/2025 (gross proceeds $121,569.50), 292 shares on 08/08/2025 ($256,489.88), and 84 shares on 08/13/2025 ($72,287.88). Several filer and issuer identification fields in the form are blank in the provided content.
Positive
- Transaction is small relative to float: 1,762 shares vs. 208,000,000 shares outstanding suggests minimal market impact
- Securities were acquired by restricted stock vesting, indicating they are compensation rather than opportunistic purchases
Negative
- Key filer and issuer identification fields are blank in the provided excerpt, limiting transparency
- Rapid disposition: acquisition on 08/17/2025 with proposed sale on 08/18/2025 may raise routine governance questions about holding period, though no rule violations are alleged in the form
Insights
TL;DR: Small executive/insider sale from recent restricted stock vesting; transaction sizes are immaterial relative to 208M shares outstanding.
The notice documents a proposed sale of 1,762 vested restricted shares with an indicated market value of $1.53M and an intended trade date of 08/18/2025 via Fidelity. Past reported disposals by Gina Marie Mastantuono total 494 shares across May and August 2025, generating roughly $450k in gross proceeds. The filing lacks issuer identification fields in the provided excerpt, limiting assessment of context such as insider role or ownership stake. From a market-impact perspective, 1,762 shares represent a de minimis portion of the reported 208,000,000 shares outstanding, so the direct supply effect is negligible.
TL;DR: Disclosure shows routine insider monetization of vested equity; form format is standard but some issuer/filer metadata is missing.
The table indicates acquisition by restricted stock vesting on 08/17/2025 and sale planned the following day, consistent with post-vesting disposition. The signature/filing contact fields in the supplied content are blank, and the issuer name is not shown in the excerpt; that missing metadata reduces traceability for shareholders. No material single-sale concentration or unusual trading plan details are present in the visible content.